Empyema due to Aggregatibacter aphrophilus and Parvimonas micra coinfection

Arch Bronconeumol. 2015 May;51(5):254-5. doi: 10.1016/j.arbres.2014.06.014. Epub 2014 Aug 17.

[Article in English, Spanish]

Authors

Santiago Rodriguez-Segade¹, David Velasco², Pedro J Marcos³

Affiliations

¹ Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), SERGAS, A Coruña, España.
² Servicio de Microbiología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), SERGAS, A Coruña, España.
³ Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña (CHUAC), Instituto de Investigación Biomédica de A Coruña (INIBIC), SERGAS, A Coruña, España. Electronic address: [email protected].

PMID: 25138795
DOI: 10.1016/j.arbres.2014.06.014

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aggregatibacter aphrophilus / isolation & purification*
Alcoholism / complications
Amoxicillin-Potassium Clavulanate Combination / therapeutic use
Anti-Bacterial Agents / therapeutic use
Chest Tubes
Coinfection
Drainage
Drug Therapy, Combination
Empyema, Pleural / drug therapy
Empyema, Pleural / etiology*
Empyema, Pleural / microbiology
Empyema, Pleural / surgery
Gram-Positive Bacterial Infections / complications*
Gram-Positive Bacterial Infections / drug therapy
Humans
Imipenem / therapeutic use
Linezolid / therapeutic use
Male
Middle Aged
Pasteurellaceae Infections / complications*
Pasteurellaceae Infections / drug therapy
Pasteurellaceae Infections / microbiology
Pasteurellaceae Infections / surgery
Peptostreptococcus / isolation & purification*
Pulmonary Atelectasis / etiology
Risk Factors
Smoking / adverse effects

Substances

Anti-Bacterial Agents
Imipenem
Amoxicillin-Potassium Clavulanate Combination
Linezolid